ArticleTherapeutic advances in psychopharmacology2026

Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics: recent clinical findings from randomized trials.

Ravi Anand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.